AAAAAA
Results: 1-25/36
Authors:
Catalano, V
Baldelli, AM
Giordani, P
Cascinu, S
Citation: V. Catalano et al., Molecular markers predictive of response to chemotherapy in gastrointestinal tumors, CR R ONC H, 38(2), 2001, pp. 93-104
Authors:
Pergolizzi, S
Settineri, N
Santacaterina, A
Spadaro, P
Maisano, R
Caristi, N
Adamo, V
De Renzis, C
Mesiti, M
Cascinu, S
Citation: S. Pergolizzi et al., Ipsilateral supraclavicular lymph nodes metastases from breast cancer as only site of disseminated disease. Chemotherapy alone vs. induction chemotherapy to radical radiation therapy, ANN ONCOL, 12(8), 2001, pp. 1091-1095
Authors:
Cascinu, S
Labianca, R
Daniele, B
Beretta, G
Salvagni, S
Citation: S. Cascinu et al., Survival and quality of life in gastrointestinal tumors: Two different endpoints?, ANN ONCOL, 12, 2001, pp. S31-S36
Authors:
Cascinu, S
Graziano, F
Valentini, M
Catalano, V
Giordani, P
Staccioli, MP
Rossi, C
Baldelli, AM
Grianti, C
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: Relationships with tumor recurrence and resistance to adjuvant chemotherapy, ANN ONCOL, 12(2), 2001, pp. 239-244
Authors:
Aragona, M
Panetta, S
Silipigni, AM
Romeo, DL
Pastura, G
Mesiti, M
Cascinu, S
La Torre, F
Citation: M. Aragona et al., Nerve growth factor receptor immunoreactivity in breast cancer patients, CANCER INV, 19(7), 2001, pp. 692-697
Authors:
Cascinu, S
Del Ferro, E
Ligi, M
Staccioli, MP
Giordani, P
Catalano, V
Agostinelli, R
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients, CANCER INV, 19(1), 2001, pp. 8-12
Authors:
Cascinu, S
Graziano, F
Catalano, V
Staccioli, MP
Barni, S
Giordani, P
Rossi, MC
Baldelli, AM
Muretto, P
Valenti, A
Catalano, G
Citation: S. Cascinu et al., Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors, CLIN EXP M, 18(8), 2001, pp. 651-655
Authors:
Casella, G
Cacopardo, E
Rovere, G
Buda, CA
Cascinu, S
Baldini, V
Citation: G. Casella et al., Cutaneous seeding after ultrasound-guided percutaneous ethanol injection for treatment of hepatocellular carcinoma, J CLIN ULTR, 29(6), 2001, pp. 354-358
Authors:
Cascinu, S
Catalano, V
Giordani, P
Baldelli, AM
Agostinelli, R
Catalano, G
Citation: S. Cascinu et al., Gastrointestinal cancer refractory to chemotherapy: A role for octreotide?, CHEMOTHERA, 47, 2001, pp. 127-133
Authors:
Cascinu, S
Graziano, F
Barni, S
Labianca, R
Comella, G
Casaretti, R
Frontini, L
Catalano, V
Baldelli, AM
Catalano, G
Citation: S. Cascinu et al., A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer, BR J CANC, 84(4), 2001, pp. 470-474
Authors:
Cascinu, S
Staccioli, MP
Gasparini, G
Giordani, P
Catalano, V
Ghiselli, R
Rossi, C
Baldelli, AM
Graziano, F
Saba, V
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer, CLIN CANC R, 6(7), 2000, pp. 2803-2807
Authors:
Aragona, M
Buda, CA
Panetta, S
Morelli, M
Giudice, A
Campagna, FL
Pontoriero, A
Cascinu, S
La Torre, F
Citation: M. Aragona et al., Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors, ONCOL REP, 7(5), 2000, pp. 987-990
Authors:
Cascinu, S
Bichisao, E
Amadori, D
Silingardi, V
Giordani, P
Sansoni, E
Luppi, G
Catalano, V
Agostinelli, R
Catalano, G
Citation: S. Cascinu et al., High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients, SUPP CARE C, 8(1), 2000, pp. 65-67
Authors:
Cascinu, S
Catalano, V
Aschele, C
Barni, S
Debernardis, D
Gallo, L
Bandelloni, R
Staccioli, MP
Baldelli, AM
Brenna, A
Valenti, A
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Immunohistochemical determination of p53 protein does not predict clinicalresponse in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination, ANN ONCOL, 11(8), 2000, pp. 1053-1056
Authors:
Mari, E
Floriani, I
Tinazzi, A
Buda, A
Belfiglio, M
Valentini, M
Cascinu, S
Barni, S
Labianca, R
Torri, V
Citation: E. Mari et al., Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials - A study of the GISCAD(Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente), ANN ONCOL, 11(7), 2000, pp. 837-843
Authors:
Graziano, F
Catalano, V
Baldelli, AM
Giordani, P
Testa, E
Lai, V
Catalano, G
Battelli, N
Cascinu, S
Citation: F. Graziano et al., A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer, ANN ONCOL, 11(10), 2000, pp. 1263-1266
Authors:
Cascinu, S
Frontini, L
Labianca, R
Catalano, V
Barni, S
Graiff, C
Picone, G
Farinati, F
Zonato, S
Pessi, MA
Curti, C
Catalano, G
Citation: S. Cascinu et al., A combination of a fixed dose rate infusion of gemcitabine associated to abolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD), ANN ONCOL, 11(10), 2000, pp. 1309-1311
Authors:
Cascinu, S
Ligi, M
Del Ferro, E
Foglietti, G
Cioccolini, P
Staccioli, MP
Carnevali, A
Rocchi, MBL
Alessandroni, P
Giordani, P
Catalano, V
Polizzi, V
Agostinelli, R
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Effects of calcium and vitamin supplementation on colon cell proliferationin colorectal cancer, CANCER INV, 18(5), 2000, pp. 411-416
Authors:
Graziano, F
Cascinu, S
Citation: F. Graziano et S. Cascinu, Docetaxel chemotherapy for pancreatic cancer: Do results support certainty?, J CL ONCOL, 18(2), 2000, pp. 445-445
Authors:
Cascinu, S
Valenti, A
Amadio, P
Mare, M
Munao, S
Crucitta, E
Raffaele, M
Picone, G
Mesiti, M
Gasparini, G
Citation: S. Cascinu et al., Angiosuppression and chemotherapy: strategies for integrating them in cancer patients, INT J B MAR, 15(2), 2000, pp. 202-202
Authors:
Mosconi, S
Cascinu, S
Zaniboni, A
Catalano, V
Giordani, P
Beretta, GD
Martignoni, G
Pancera, G
Baldelli, AM
Poletti, P
Curti, C
Labianca, R
Citation: S. Mosconi et al., The value of oxaliplatin in combination with continuous infusion +/- bolus5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: A GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial, TUMORI, 86(6), 2000, pp. 465-469
Authors:
Cascinu, S
Munao, S
Mare, M
Amadio, P
Crucitta, E
Picone, G
Citation: S. Cascinu et al., Tolerance profiles of platinum coordination compounds, TUMORI, 86(3), 2000, pp. S54-S55
Authors:
Cascinu, S
Graziano, F
Catalano, V
Valentini, M
Rossi, MC
Baldelli, AM
Ghiselli, R
Saba, V
Giordani, P
Catalano, G
Citation: S. Cascinu et al., Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy, ANTICANC R, 20(5C), 2000, pp. 3839-3842
Authors:
Cascinu, S
Aschele, C
Barni, S
Debernardis, D
Baldo, C
Tunesi, G
Catalano, V
Staccioli, MP
Brenna, A
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil, CLIN CANC R, 5(8), 1999, pp. 1996-1999
Authors:
Cascinu, S
Giordani, P
Quattrone, A
Catalano, V
Antognoli, S
Piga, A
Catalano, G
Cellerino, R
Citation: S. Cascinu et al., Intensive versus standard chemotherapy in elderly gastric cancer patients:A retrospective analysis, GI CANCER, 3(2), 1999, pp. 97-101